HC Wainwright & Co. Reiterates Buy on Nuvalent, Maintains $155 Price Target

Benzinga Newsdesk www.benzinga.com Neutral 89.4%

Neg 0% Neu 89.4% Pos 0%

HC Wainwright & Co. analyst Swayampakula Ramakanth reiterates Nuvalent (NASDAQ:NUVL) with a Buy and maintains $155 price target.